-
Je něco špatně v tomto záznamu ?
Atrial Fibrillation Ablation During Hospitalization for Acute Heart Failure: Feasibility and Role of Pulsed Field Ablation
J. Marek, P. Stojadinović, D. Wichterle, P. Peichl, J. Hašková, E. Borišincová, P. Štiavnický, R. Čihák, M. Šramko, J. Kautzner
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, srovnávací studie
Grantová podpora
This study was supported by the (Ministry of Health, Czech Republic) for development of research organization 00023001 (IKEM, Prague, Czech Republic) - Institutional support and National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, Project No. LX22NPO5104) - Funded by the European Union - Next Generation EU.
PubMed
39588593
DOI
10.1111/jce.16507
Knihovny.cz E-zdroje
- MeSH
- akční potenciály MeSH
- akutní nemoc MeSH
- časové faktory MeSH
- fibrilace síní * patofyziologie chirurgie diagnóza MeSH
- funkce levé komory srdeční * MeSH
- katetrizační ablace * škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- recidiva * MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- srdeční frekvence MeSH
- srdeční selhání * patofyziologie diagnóza terapie mortalita MeSH
- studie proveditelnosti * MeSH
- tepový objem MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
INTRODUCTION: Atrial fibrillation (AF) can cause or aggravate heart failure (HF). Catheter ablation (CA) is an effective treatment for AF. This study focused on the feasibility and outcomes of emergent AF ablation performed during hospitalization for acute HF. METHODS AND RESULTS: We retrospectively investigated patients who underwent emergent CA for AF during hospitalization for acute HF in 2018-2024. Arrhythmia recurrence was the primary endpoint. The combination of arrhythmia recurrence, HF hospitalization, and all-cause death was the secondary endpoint. Patients were censored 1 year after the index procedure. We included 46 patients, 35% females, with median age of 67 [interquartile rage: 61, 72] years and left ventricular ejection fraction (LVEF) of 25 [23, 28]%. Thermal CA was performed in 14 patients, and pulsed field ablation (PFA) in 32 patients. Procedure time was significantly shorter with PFA compared to thermal CA (77 [57, 91] vs. 166 [142, 200] minutes, p < 0.001). Fluoroscopy time was longer with PFA (9.5 [7.6, 12.0] vs. 3.9 [2.9, 6.0] minutes, p < 0.001), with a borderline trend towards higher radiation dose (75 [53, 170] vs. 50 [30, 94] μGy.m2, p = 0.056). Extrapulmonary ablation was frequent (86% and 84% for thermal CA and PFA, p > 0.9). The estimated freedom from the primary endpoint was 79% after PFA and 64% after thermal CA (p = 0.44). The estimated freedom from the secondary endpoint was 76% after PFA and 57% after thermal CA (p = 0.43). LVEF improved by 24% ± 2% (p < 0.001) in patients with the first manifestation of HF and by 14% ± 4% (p = .004) in patients with decompensated HF diagnosed earlier. CONCLUSIONS: Emergent CA of AF during acute HF hospitalization is safe and associated with improved LVEF and good clinical outcomes. In the PFA era, the rate of these procedures is progressively increasing as they are readily available and easy to perform compared to thermal ablation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010462
- 003
- CZ-PrNML
- 005
- 20250429134650.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jce.16507 $2 doi
- 035 __
- $a (PubMed)39588593
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Marek, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia $u 2nd Department of Medicine - Department of Cardiovascular Medicine, Charles University Medical School I, Prague, Czechia $1 https://orcid.org/0000000215475696
- 245 10
- $a Atrial Fibrillation Ablation During Hospitalization for Acute Heart Failure: Feasibility and Role of Pulsed Field Ablation / $c J. Marek, P. Stojadinović, D. Wichterle, P. Peichl, J. Hašková, E. Borišincová, P. Štiavnický, R. Čihák, M. Šramko, J. Kautzner
- 520 9_
- $a INTRODUCTION: Atrial fibrillation (AF) can cause or aggravate heart failure (HF). Catheter ablation (CA) is an effective treatment for AF. This study focused on the feasibility and outcomes of emergent AF ablation performed during hospitalization for acute HF. METHODS AND RESULTS: We retrospectively investigated patients who underwent emergent CA for AF during hospitalization for acute HF in 2018-2024. Arrhythmia recurrence was the primary endpoint. The combination of arrhythmia recurrence, HF hospitalization, and all-cause death was the secondary endpoint. Patients were censored 1 year after the index procedure. We included 46 patients, 35% females, with median age of 67 [interquartile rage: 61, 72] years and left ventricular ejection fraction (LVEF) of 25 [23, 28]%. Thermal CA was performed in 14 patients, and pulsed field ablation (PFA) in 32 patients. Procedure time was significantly shorter with PFA compared to thermal CA (77 [57, 91] vs. 166 [142, 200] minutes, p < 0.001). Fluoroscopy time was longer with PFA (9.5 [7.6, 12.0] vs. 3.9 [2.9, 6.0] minutes, p < 0.001), with a borderline trend towards higher radiation dose (75 [53, 170] vs. 50 [30, 94] μGy.m2, p = 0.056). Extrapulmonary ablation was frequent (86% and 84% for thermal CA and PFA, p > 0.9). The estimated freedom from the primary endpoint was 79% after PFA and 64% after thermal CA (p = 0.44). The estimated freedom from the secondary endpoint was 76% after PFA and 57% after thermal CA (p = 0.43). LVEF improved by 24% ± 2% (p < 0.001) in patients with the first manifestation of HF and by 14% ± 4% (p = .004) in patients with decompensated HF diagnosed earlier. CONCLUSIONS: Emergent CA of AF during acute HF hospitalization is safe and associated with improved LVEF and good clinical outcomes. In the PFA era, the rate of these procedures is progressively increasing as they are readily available and easy to perform compared to thermal ablation.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a srdeční selhání $x patofyziologie $x diagnóza $x terapie $x mortalita $7 D006333
- 650 12
- $a fibrilace síní $x patofyziologie $x chirurgie $x diagnóza $7 D001281
- 650 12
- $a studie proveditelnosti $7 D005240
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a katetrizační ablace $x škodlivé účinky $7 D017115
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a recidiva $7 D012008
- 650 12
- $a funkce levé komory srdeční $7 D016277
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a tepový objem $7 D013318
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a srdeční frekvence $7 D006339
- 650 _2
- $a akční potenciály $7 D000200
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Stojadinović, Predrag $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia $1 https://orcid.org/0000000214875823
- 700 1_
- $a Wichterle, Dan $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia $u 2nd Department of Medicine - Department of Cardiovascular Medicine, Charles University Medical School I, Prague, Czechia $1 https://orcid.org/0000000204485143 $7 xx0101417
- 700 1_
- $a Peichl, Petr $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Hašková, Jana $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Borišincová, Eva $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Štiavnický, Petr $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Čihák, Robert $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Šramko, Marek $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 773 0_
- $w MED00002569 $t Journal of cardiovascular electrophysiology $x 1540-8167 $g Roč. 36, č. 1 (2025), s. 256-265
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39588593 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134646 $b ABA008
- 999 __
- $a ok $b bmc $g 2311673 $s 1247543
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 36 $c 1 $d 256-265 $e 20241126 $i 1540-8167 $m Journal of cardiovascular electrophysiology $n J Cardiovasc Electrophysiol $x MED00002569
- GRA __
- $p This study was supported by the (Ministry of Health, Czech Republic) for development of research organization 00023001 (IKEM, Prague, Czech Republic) - Institutional support and National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, Project No. LX22NPO5104) - Funded by the European Union - Next Generation EU.
- LZP __
- $a Pubmed-20250415
